Patent · US Expired

Azabicyclo derivatives as muscarinic receptor antagonists

US7544708B2 · kind B2 · utility

0Cited by
14References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2003
Grant dateJun 9, 2009
Priority date
Expiry dateAug 13, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Specifically, the invention relates to derivatives of azabicyclo compounds, including, for example, 6-substituted azabicyclo[3.1.0] hexanes, and 2,4,6-trisubstituted derivatives. The invention also relates to pharmaceutical compositions containing the compounds and the methods of treating the diseases mediated through muscarinic receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.